CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test sale cost 4400 AED
PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant Genetic Test sale cost 4400 AED PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test sale cost 4400 AED COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test” is a specialized diagnostic examination conducted to identify mutations in the CACNA1A gene, which are implicated in Spinocerebellar Ataxia Type 6 (SCA6). SCA6 is a genetic disorder characterized by progressive degeneration of the cerebellum, leading to coordination and balance difficulties, among other symptoms. This condition follows an autosomal dominant inheritance pattern, meaning that an affected individual has a 50% chance of passing the mutation to their offspring.

The test is specifically designed to detect the presence of genetic alterations within the CACNA1A gene, which encodes a subunit of a calcium channel that plays a critical role in the functioning of nerve cells, particularly in the cerebellum. Mutations in this gene disrupt the normal flow of calcium ions, leading to the symptoms associated with SCA6.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis for individuals presenting symptoms of SCA6 or those with a family history of the disorder. It is a crucial step in confirming the diagnosis, understanding the risk of transmission to future generations, and guiding management and treatment options.

The cost of the “CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test” at DNA Labs UAE is set at 4400 AED. This investment covers the technical processes of detecting the specific genetic mutation, professional analysis, and the provision of a detailed report on the findings. It’s an essential tool for individuals and families seeking clarity on their genetic status concerning SCA6, facilitating informed decisions regarding health and family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test

Welcome to DNA Labs UAE, your trusted genetic testing laboratory. We offer the CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test for individuals who may be at risk of this genetic disorder. Our comprehensive test provides accurate results and valuable information for diagnosis and treatment options.

Test Details

The CACNA1A gene is associated with a condition called spinocerebellar ataxia type 6 (SCA6). SCA6 is an autosomal dominant genetic disorder that affects the cerebellum, which is the part of the brain responsible for coordinating movement.

Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, providing a comprehensive analysis of the CACNA1A gene. This advanced testing method can identify mutations or variations in the gene that are associated with SCA6.

By analyzing the CACNA1A gene, our NGS testing can determine if a person has a mutation or variation that is known to cause SCA6. This information is crucial for accurate diagnosis, genetic counseling, and treatment planning.

It’s important to note that our NGS genetic testing can also identify other genetic variations that may not be directly related to SCA6 but could have implications for an individual’s health. Therefore, it’s essential to consult with a healthcare professional or genetic counselor to interpret the results accurately and understand their implications.

Test Components and Price

Our CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test is priced at AED 4400.0.

Components:

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre-Test Information

Before undergoing the CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with this genetic disorder. This information is crucial for accurate interpretation of the test results.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test can provide valuable insights into your genetic health. Contact us today to schedule your test and take control of your genetic well-being.

Test Name CACNA1A Gene Spinocerebellar ataxia type 6 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CACNA1A Gene Spinocerebellar ataxia type 6, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1A Gene Spinocerebellar ataxia type 6, autosomal dominant
Test Details

The CACNA1A gene is associated with a condition called spinocerebellar ataxia type 6 (SCA6). SCA6 is an autosomal dominant genetic disorder that affects the cerebellum, which is the part of the brain responsible for coordinating movement.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SCA6, NGS genetic testing can identify mutations or variations in the CACNA1A gene that are associated with the condition.

By analyzing the CACNA1A gene, NGS testing can determine if a person has a mutation or variation in the gene that is known to cause SCA6. This information can be used for diagnosis, genetic counseling, and to guide treatment options.

It’s important to note that NGS genetic testing can also identify other genetic variations that may not be directly related to SCA6 but could have implications for an individual’s health. Therefore, it’s essential to consult with a healthcare professional or genetic counselor to interpret the results accurately and understand their implications.

SKU: TEST-2078 Category:

Related products